Eva M. Guerra-Alia

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Corrigendum to "HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study" [Gynecologic Oncology 194 (2025) 33-40].

Corrigendum to "HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study" [Gynecologic Oncology 194 (2025) 33-40].

Journal: Gynecologic oncology
Published: November 09, 2025

A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2).

A randomized, phase III study of sacituzumab govitecan versus treatment of the physician's choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 20, 2025

Needs and opportunities for improvement in the management and monitoring of gynaecological cancer in Spain.

Needs and opportunities for improvement in the management and monitoring of gynaecological cancer in Spain.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 24, 2025

Management and Clinical Outcomes of Patients with Advanced Ovarian Cancer in Routine Clinical Practice in Spain: The OVOC Study.

Management and Clinical Outcomes of Patients with Advanced Ovarian Cancer in Routine Clinical Practice in Spain: The OVOC Study.

Journal: Oncology and therapy
Published: December 20, 2024

HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study.

HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study.

Journal: Gynecologic oncology
Published: November 06, 2024

SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023).

SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 17, 2024

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Journal: The oncologist
Published: April 15, 2024

Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study.

Journal: The oncologist
Published: March 11, 2024

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.

Journal: Gynecologic oncology
Published: October 20, 2023

Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice.

Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice.

Journal: Frontiers in oncology
Published: September 29, 2023

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 05, 2023

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).

Journal: International journal of molecular sciences
Published: May 09, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026